---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-105537"
form_type: "8-K"
ticker: "TCMD"
cik: "0001027838"
company_name: "TACTILE SYSTEMS TECHNOLOGY INC"
filed_at: "2025-11-03T23:59:59+00:00"
generated_at: "2026-05-17T00:48:44.045497+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Tactile Medical Q3 net income $8.2M, revenue up 17%; raises FY guidance and authorizes $25M buyback

## Summary
- Q3 revenue $85.8M (+17% YoY), net income $8.2M ($0.36 diluted EPS) vs $5.2M ($0.21) in Q3 2024.
- Adjusted EBITDA $14.4M vs $10.7M YoY; gross margin 76% vs 75%.
- Paid off $24M term loan, refinanced revolver to $40M; cash $66M.
- Authorized $25M share buyback program through Nov 2027.
- FY 2025 guidance raised: revenue $317-321M (prior $310-315M), adj. EBITDA $38-39.5M (prior $33-35M).

## SEC filing metadata
- accession: 0001104659-25-105537
- form_type: 8-K
- ticker: TCMD
- cik: 0001027838
- company_name: TACTILE SYSTEMS TECHNOLOGY INC
- filed_at: 2025-11-03T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1027838/000110465925105537/0001104659-25-105537-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1027838/000110465925105537/tcmd-20251103x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-105537
- JSON: https://secwatch.observer/filing/0001104659-25-105537.json
- Plain text: https://secwatch.observer/filing/0001104659-25-105537.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.